APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Uric Acid-lowering Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Uric Acid-lowering Drugs Market Analysis and Forecast 2026-2032

Report ID 17404452021 January 2026191 pages

Choose your research edition.

Industry ResearchUric Acid-lowering Drugs Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Uric Acid-lowering Drugs Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Uric Acid-lowering Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Uric Acid-lowering Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Uric Acid-lowering Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Uric Acid-lowering Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Uric Acid-lowering Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Uric Acid-lowering Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Uric Acid-lowering Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Uric Acid-lowering Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Uric Acid-lowering Drugs include Takeda Pharmaceuticals, Teva, Sanwa Kagaku Kenkyusho, Sanofi, GSK, AstraZeneca, Towa Pharmaceutical, Toa Eiyo and Mylan Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Uric Acid-lowering Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Uric Acid-lowering Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Uric Acid-lowering Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Uric Acid-lowering Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Uric Acid-lowering Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Uric Acid-lowering Drugs sales, projected growth trends, production technology, application and end-user industry.

Uric Acid-lowering Drugs Segment by Company

Takeda Pharmaceuticals

Teva

Sanwa Kagaku Kenkyusho

Sanofi

GSK

AstraZeneca

Towa Pharmaceutical

Toa Eiyo

Mylan Pharmaceuticals

Mochida Pharmaceutical

Lannett Company

Horizo​​n Therapeutics

Fuji Yakuhin

Uric Acid-lowering Drugs Segment by Type

Uric Acid Production Inhibitors

Uric Acid Dissolving Agents

Urate-stimulating Excretion Agents

Uric Acid-lowering Drugs Segment by Application

Hyperuricemia

Uric Acid Kidney Stones

Gout

Other

Uric Acid-lowering Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Uric Acid-lowering Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Uric Acid-lowering Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Uric Acid-lowering Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Uric Acid-lowering Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Uric Acid-lowering Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Uric Acid-lowering Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Uric Acid-lowering Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Uric Acid Production Inhibitors Major Manufacturers Table 3. Uric Acid Dissolving Agents Major Manufacturers Table 4. Urate-stimulating Excretion Agents Major Manufacturers Table 5. Global Uric Acid-lowering Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hyperuricemia Major Manufacturers Table 7. Uric Acid Kidney Stones Major Manufacturers Table 8. Gout Major Manufacturers Table 9. Other Major Manufacturers Table 10. Uric Acid-lowering Drugs Industry Trends Table 11. Uric Acid-lowering Drugs Industry Drivers Table 12. Uric Acid-lowering Drugs Industry Opportunities and Challenges Table 13. Uric Acid-lowering Drugs Industry Restraints Table 14. Global Uric Acid-lowering Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Uric Acid-lowering Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Uric Acid-lowering Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Uric Acid-lowering Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Uric Acid-lowering Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Uric Acid-lowering Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 20. Global Uric Acid-lowering Drugs Sales by Region (2021-2026) & (Units) Table 21. Global Uric Acid-lowering Drugs Sales by Region (2027-2032) & (Units) Table 22. Global Uric Acid-lowering Drugs Sales Market Share by Region (2021-2026) Table 23. Global Uric Acid-lowering Drugs Sales Market Share by Region (2027-2032) Table 24. Global Uric Acid-lowering Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Uric Acid-lowering Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Uric Acid-lowering Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Uric Acid-lowering Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Uric Acid-lowering Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Uric Acid-lowering Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Uric Acid-lowering Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Uric Acid-lowering Drugs Manufacturers, Product Type & Application Table 32. Global Uric Acid-lowering Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Uric Acid-lowering Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Uric Acid-lowering Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Uric Acid-lowering Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Uric Acid-lowering Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Uric Acid-lowering Drugs Sales by Type 2021 VS 2025 VS 2032 (Units) Table 41. Global Uric Acid-lowering Drugs Sales by Type (2021-2026) & (Units) Table 42. Global Uric Acid-lowering Drugs Sales by Type (2027-2032) & (Units) Table 43. Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026) Table 44. Global Uric Acid-lowering Drugs Sales Market Share by Type (2027-2032) Table 45. Global Uric Acid-lowering Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Uric Acid-lowering Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Uric Acid-lowering Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Uric Acid-lowering Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Uric Acid-lowering Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Uric Acid-lowering Drugs Sales by Application 2021 VS 2025 VS 2032 (Units) Table 53. Global Uric Acid-lowering Drugs Sales by Application (2021-2026) & (Units) Table 54. Global Uric Acid-lowering Drugs Sales by Application (2027-2032) & (Units) Table 55. Global Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026) Table 56. Global Uric Acid-lowering Drugs Sales Market Share by Application (2027-2032) Table 57. Global Uric Acid-lowering Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Uric Acid-lowering Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Takeda Pharmaceuticals Company Information Table 60. Takeda Pharmaceuticals Business Overview Table 61. Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Takeda Pharmaceuticals Uric Acid-lowering Drugs Product Portfolio Table 63. Takeda Pharmaceuticals Recent Development Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Uric Acid-lowering Drugs Product Portfolio Table 68. Teva Recent Development Table 69. Sanwa Kagaku Kenkyusho Company Information Table 70. Sanwa Kagaku Kenkyusho Business Overview Table 71. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product Portfolio Table 73. Sanwa Kagaku Kenkyusho Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sanofi Uric Acid-lowering Drugs Product Portfolio Table 78. Sanofi Recent Development Table 79. GSK Company Information Table 80. GSK Business Overview Table 81. GSK Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GSK Uric Acid-lowering Drugs Product Portfolio Table 83. GSK Recent Development Table 84. AstraZeneca Company Information Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZeneca Uric Acid-lowering Drugs Product Portfolio Table 88. AstraZeneca Recent Development Table 89. Towa Pharmaceutical Company Information Table 90. Towa Pharmaceutical Business Overview Table 91. Towa Pharmaceutical Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Towa Pharmaceutical Uric Acid-lowering Drugs Product Portfolio Table 93. Towa Pharmaceutical Recent Development Table 94. Toa Eiyo Company Information Table 95. Toa Eiyo Business Overview Table 96. Toa Eiyo Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Toa Eiyo Uric Acid-lowering Drugs Product Portfolio Table 98. Toa Eiyo Recent Development Table 99. Mylan Pharmaceuticals Company Information Table 100. Mylan Pharmaceuticals Business Overview Table 101. Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mylan Pharmaceuticals Uric Acid-lowering Drugs Product Portfolio Table 103. Mylan Pharmaceuticals Recent Development Table 104. Mochida Pharmaceutical Company Information Table 105. Mochida Pharmaceutical Business Overview Table 106. Mochida Pharmaceutical Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Mochida Pharmaceutical Uric Acid-lowering Drugs Product Portfolio Table 108. Mochida Pharmaceutical Recent Development Table 109. Lannett Company Company Information Table 110. Lannett Company Business Overview Table 111. Lannett Company Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lannett Company Uric Acid-lowering Drugs Product Portfolio Table 113. Lannett Company Recent Development Table 114. Horizo​​n Therapeutics Company Information Table 115. Horizo​​n Therapeutics Business Overview Table 116. Horizo​​n Therapeutics Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Horizo​​n Therapeutics Uric Acid-lowering Drugs Product Portfolio Table 118. Horizo​​n Therapeutics Recent Development Table 119. Fuji Yakuhin Company Information Table 120. Fuji Yakuhin Business Overview Table 121. Fuji Yakuhin Uric Acid-lowering Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Fuji Yakuhin Uric Acid-lowering Drugs Product Portfolio Table 123. Fuji Yakuhin Recent Development Table 124. North America Uric Acid-lowering Drugs Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Uric Acid-lowering Drugs Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Uric Acid-lowering Drugs Sales by Type (2021-2026) & (Units) Table 127. North America Uric Acid-lowering Drugs Sales by Type (2027-2032) & (Units) Table 128. North America Uric Acid-lowering Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 129. North America Uric Acid-lowering Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 130. North America Uric Acid-lowering Drugs Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Uric Acid-lowering Drugs Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Uric Acid-lowering Drugs Sales by Application (2021-2026) & (Units) Table 133. North America Uric Acid-lowering Drugs Sales by Application (2027-2032) & (Units) Table 134. North America Uric Acid-lowering Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 135. North America Uric Acid-lowering Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 136. North America Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. North America Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. North America Uric Acid-lowering Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. North America Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 140. North America Uric Acid-lowering Drugs Sales by Country (2021-2026) & (Units) Table 141. North America Uric Acid-lowering Drugs Sales by Country (2027-2032) & (Units) Table 142. North America Uric Acid-lowering Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 143. North America Uric Acid-lowering Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 144. United States Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 145. Canada Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 146. Europe Uric Acid-lowering Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Uric Acid-lowering Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Uric Acid-lowering Drugs Sales by Type (2021-2026) & (Units) Table 149. Europe Uric Acid-lowering Drugs Sales by Type (2027-2032) & (Units) Table 150. Europe Uric Acid-lowering Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Uric Acid-lowering Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Uric Acid-lowering Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Uric Acid-lowering Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Uric Acid-lowering Drugs Sales by Application (2021-2026) & (Units) Table 155. Europe Uric Acid-lowering Drugs Sales by Application (2027-2032) & (Units) Table 156. Europe Uric Acid-lowering Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Uric Acid-lowering Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Uric Acid-lowering Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 162. Europe Uric Acid-lowering Drugs Sales by Country (2021-2026) & (Units) Table 163. Europe Uric Acid-lowering Drugs Sales by Country (2027-2032) & (Units) Table 164. Europe Uric Acid-lowering Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Uric Acid-lowering Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 167. France Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 168. U.K. Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 169. Italy Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 170. Netherlands Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 171. China Uric Acid-lowering Drugs Revenue by Type (2021-2026) & (US$ Million) Table 172. China Uric Acid-lowering Drugs Revenue by Type (2027-2032) & (US$ Million) Table 173. China Uric Acid-lowering Drugs Sales by Type (2021-2026) & (Units) Table 174. China Uric Acid-lowering Drugs Sales by Type (2027-2032) & (Units) Table 175. China Uric Acid-lowering Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 176. China Uric Acid-lowering Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 177. China Uric Acid-lowering Drugs Revenue by Application (2021-2026) & (US$ Million) Table 178. China Uric Acid-lowering Drugs Revenue by Application (2027-2032) & (US$ Million) Table 179. China Uric Acid-lowering Drugs Sales by Application (2021-2026) & (Units) Table 180. China Uric Acid-lowering Drugs Sales by Application (2027-2032) & (Units) Table 181. China Uric Acid-lowering Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 182. China Uric Acid-lowering Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Uric Acid-lowering Drugs Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Uric Acid-lowering Drugs Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Uric Acid-lowering Drugs Sales by Type (2021-2026) & (Units) Table 186. Asia Uric Acid-lowering Drugs Sales by Type (2027-2032) & (Units) Table 187. Asia Uric Acid-lowering Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 188. Asia Uric Acid-lowering Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 189. Asia Uric Acid-lowering Drugs Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Uric Acid-lowering Drugs Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Uric Acid-lowering Drugs Sales by Application (2021-2026) & (Units) Table 192. Asia Uric Acid-lowering Drugs Sales by Application (2027-2032) & (Units) Table 193. Asia Uric Acid-lowering Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 194. Asia Uric Acid-lowering Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Uric Acid-lowering Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 199. Asia Uric Acid-lowering Drugs Sales by Country (2021-2026) & (Units) Table 200. Asia Uric Acid-lowering Drugs Sales by Country (2027-2032) & (Units) Table 201. Asia Uric Acid-lowering Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 202. Asia Uric Acid-lowering Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Japan Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 204. South Korea Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 205. India Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 206. Australia Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 207. China Taiwan Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Uric Acid-lowering Drugs Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Uric Acid-lowering Drugs Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Uric Acid-lowering Drugs Sales by Type (2021-2026) & (Units) Table 212. SAMEA Uric Acid-lowering Drugs Sales by Type (2027-2032) & (Units) Table 213. SAMEA Uric Acid-lowering Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 214. SAMEA Uric Acid-lowering Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 215. SAMEA Uric Acid-lowering Drugs Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Uric Acid-lowering Drugs Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Uric Acid-lowering Drugs Sales by Application (2021-2026) & (Units) Table 218. SAMEA Uric Acid-lowering Drugs Sales by Application (2027-2032) & (Units) Table 219. SAMEA Uric Acid-lowering Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 220. SAMEA Uric Acid-lowering Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 221. SAMEA Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Uric Acid-lowering Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 225. SAMEA Uric Acid-lowering Drugs Sales by Country (2021-2026) & (Units) Table 226. SAMEA Uric Acid-lowering Drugs Sales by Country (2027-2032) & (Units) Table 227. SAMEA Uric Acid-lowering Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 228. SAMEA Uric Acid-lowering Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 229. Brazil Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 230. Argentina Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 231. Chile Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 232. Colombia Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 233. Peru Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 235. Israel Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 236. UAE Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 237. Turkey Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 238. Iran Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 239. Egypt Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Uric Acid-lowering Drugs Distributors List Table 243. Uric Acid-lowering Drugs Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Uric Acid-lowering Drugs Image Figure 2. Global Uric Acid-lowering Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Uric Acid-lowering Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Uric Acid Production Inhibitors Image Figure 5. Uric Acid Dissolving Agents Image Figure 6. Urate-stimulating Excretion Agents Image Figure 7. Global Uric Acid-lowering Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Uric Acid-lowering Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hyperuricemia Image Figure 10. Uric Acid Kidney Stones Image Figure 11. Gout Image Figure 12. Other Image Figure 13. Global Uric Acid-lowering Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Uric Acid-lowering Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Uric Acid-lowering Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Uric Acid-lowering Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Uric Acid-lowering Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Uric Acid-lowering Drugs Sales (2021-2032) & (Units) Figure 19. Global Uric Acid-lowering Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 20. Global Uric Acid-lowering Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Uric Acid-lowering Drugs Sales YoY (2021-2032) & (Units) Figure 22. Europe Uric Acid-lowering Drugs Sales YoY (2021-2032) & (Units) Figure 23. China Uric Acid-lowering Drugs Sales YoY (2021-2032) & (Units) Figure 24. Asia (Excluding China) Uric Acid-lowering Drugs Sales YoY (2021-2032) & (Units) Figure 25. South America, Middle East and Africa Uric Acid-lowering Drugs Sales YoY (2021-2032) & (Units) Figure 26. Global Uric Acid-lowering Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Uric Acid-lowering Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Uric Acid-lowering Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Uric Acid-lowering Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Uric Acid-lowering Drugs Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 33. Global Uric Acid-lowering Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Uric Acid-lowering Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Uric Acid-lowering Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Uric Acid-lowering Drugs Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 39. Global Uric Acid-lowering Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Uric Acid-lowering Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Uric Acid-lowering Drugs Revenue Share by Type (2021-2032) Figure 42. North America Uric Acid-lowering Drugs Sales Share by Type (2021-2032) Figure 43. North America Uric Acid-lowering Drugs Revenue Share by Application (2021-2032) Figure 44. North America Uric Acid-lowering Drugs Sales Share by Application (2021-2032) Figure 45. North America Uric Acid-lowering Drugs Revenue Share by Country (2021-2032) Figure 46. North America Uric Acid-lowering Drugs Sales Share by Country (2021-2032) Figure 47. Europe Uric Acid-lowering Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Uric Acid-lowering Drugs Sales Share by Type (2021-2032) Figure 49. Europe Uric Acid-lowering Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Uric Acid-lowering Drugs Sales Share by Application (2021-2032) Figure 51. Europe Uric Acid-lowering Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Uric Acid-lowering Drugs Sales Share by Country (2021-2032) Figure 53. China Uric Acid-lowering Drugs Revenue Share by Type (2021-2032) Figure 54. China Uric Acid-lowering Drugs Sales Share by Type (2021-2032) Figure 55. China Uric Acid-lowering Drugs Revenue Share by Application (2021-2032) Figure 56. China Uric Acid-lowering Drugs Sales Share by Application (2021-2032) Figure 57. Asia Uric Acid-lowering Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Uric Acid-lowering Drugs Sales Share by Type (2021-2032) Figure 59. Asia Uric Acid-lowering Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Uric Acid-lowering Drugs Sales Share by Application (2021-2032) Figure 61. Asia Uric Acid-lowering Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Uric Acid-lowering Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Uric Acid-lowering Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Uric Acid-lowering Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Uric Acid-lowering Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Uric Acid-lowering Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Uric Acid-lowering Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Uric Acid-lowering Drugs Sales Share by Country (2021-2032) Figure 69. Uric Acid-lowering Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Uric Acid-lowering Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Uric Acid Production Inhibitors
  • Uric Acid Dissolving Agents
  • Urate-stimulating Excretion Agents
Applications
  • Hyperuricemia
  • Uric Acid Kidney Stones
  • Gout
  • Other
Companies covered
  • Takeda Pharmaceuticals
  • Teva
  • Sanwa Kagaku Kenkyusho
  • Sanofi
  • GSK
  • AstraZeneca
  • Towa Pharmaceutical
  • Toa Eiyo
  • Mylan Pharmaceuticals
  • Mochida Pharmaceutical
  • Lannett Company
  • Horizo​​n Therapeutics
  • Fuji Yakuhin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Uric Acid-lowering Drugs Market by Type
  3. 1.2.1 Global Uric Acid-lowering Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Uric Acid Production Inhibitors
  5. 1.2.3 Uric Acid Dissolving Agents
  6. 1.2.4 Urate-stimulating Excretion Agents
  7. 1.3 Uric Acid-lowering Drugs Market by Application
  8. 1.3.1 Global Uric Acid-lowering Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hyperuricemia
  10. 1.3.3 Uric Acid Kidney Stones
  11. 1.3.4 Gout
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Uric Acid-lowering Drugs Market Dynamics
  1. 2.1 Uric Acid-lowering Drugs Industry Trends
  2. 2.2 Uric Acid-lowering Drugs Industry Drivers
  3. 2.3 Uric Acid-lowering Drugs Industry Opportunities and Challenges
  4. 2.4 Uric Acid-lowering Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Uric Acid-lowering Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Uric Acid-lowering Drugs Revenue by Region
  3. 3.2.1 Global Uric Acid-lowering Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Uric Acid-lowering Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Uric Acid-lowering Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Uric Acid-lowering Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Uric Acid-lowering Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Uric Acid-lowering Drugs Sales by Region
  9. 3.4.1 Global Uric Acid-lowering Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Uric Acid-lowering Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Uric Acid-lowering Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Uric Acid-lowering Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Uric Acid-lowering Drugs Revenue by Manufacturers
  2. 4.1.1 Global Uric Acid-lowering Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Uric Acid-lowering Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Uric Acid-lowering Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Uric Acid-lowering Drugs Sales by Manufacturers
  6. 4.2.1 Global Uric Acid-lowering Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Uric Acid-lowering Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Uric Acid-lowering Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Uric Acid-lowering Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Uric Acid-lowering Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Uric Acid-lowering Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Uric Acid-lowering Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Uric Acid-lowering Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Uric Acid-lowering Drugs Market CR5 and HHI
  16. 4.8.2 2025 Uric Acid-lowering Drugs Tier 1, Tier 2, and Tier 3
5 Uric Acid-lowering Drugs Market by Type
  1. 5.1 Global Uric Acid-lowering Drugs Revenue by Type
  2. 5.1.1 Global Uric Acid-lowering Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Uric Acid-lowering Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Uric Acid-lowering Drugs Sales by Type
  6. 5.2.1 Global Uric Acid-lowering Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Uric Acid-lowering Drugs Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Uric Acid-lowering Drugs Price by Type
6 Uric Acid-lowering Drugs Market by Application
  1. 6.1 Global Uric Acid-lowering Drugs Revenue by Application
  2. 6.1.1 Global Uric Acid-lowering Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Uric Acid-lowering Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Uric Acid-lowering Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Uric Acid-lowering Drugs Sales by Application
  6. 6.2.1 Global Uric Acid-lowering Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Uric Acid-lowering Drugs Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Uric Acid-lowering Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Uric Acid-lowering Drugs Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceuticals
  2. 7.1.1 Takeda Pharmaceuticals Company Information
  3. 7.1.2 Takeda Pharmaceuticals Business Overview
  4. 7.1.3 Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceuticals Uric Acid-lowering Drugs Product Portfolio
  6. 7.1.5 Takeda Pharmaceuticals Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Uric Acid-lowering Drugs Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Sanwa Kagaku Kenkyusho
  14. 7.3.1 Sanwa Kagaku Kenkyusho Company Information
  15. 7.3.2 Sanwa Kagaku Kenkyusho Business Overview
  16. 7.3.3 Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product Portfolio
  18. 7.3.5 Sanwa Kagaku Kenkyusho Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Uric Acid-lowering Drugs Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 GSK
  26. 7.5.1 GSK Company Information
  27. 7.5.2 GSK Business Overview
  28. 7.5.3 GSK Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GSK Uric Acid-lowering Drugs Product Portfolio
  30. 7.5.5 GSK Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Uric Acid-lowering Drugs Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Towa Pharmaceutical
  38. 7.7.1 Towa Pharmaceutical Company Information
  39. 7.7.2 Towa Pharmaceutical Business Overview
  40. 7.7.3 Towa Pharmaceutical Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Towa Pharmaceutical Uric Acid-lowering Drugs Product Portfolio
  42. 7.7.5 Towa Pharmaceutical Recent Developments
  43. 7.8 Toa Eiyo
  44. 7.8.1 Toa Eiyo Company Information
  45. 7.8.2 Toa Eiyo Business Overview
  46. 7.8.3 Toa Eiyo Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Toa Eiyo Uric Acid-lowering Drugs Product Portfolio
  48. 7.8.5 Toa Eiyo Recent Developments
  49. 7.9 Mylan Pharmaceuticals
  50. 7.9.1 Mylan Pharmaceuticals Company Information
  51. 7.9.2 Mylan Pharmaceuticals Business Overview
  52. 7.9.3 Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mylan Pharmaceuticals Uric Acid-lowering Drugs Product Portfolio
  54. 7.9.5 Mylan Pharmaceuticals Recent Developments
  55. 7.10 Mochida Pharmaceutical
  56. 7.10.1 Mochida Pharmaceutical Company Information
  57. 7.10.2 Mochida Pharmaceutical Business Overview
  58. 7.10.3 Mochida Pharmaceutical Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mochida Pharmaceutical Uric Acid-lowering Drugs Product Portfolio
  60. 7.10.5 Mochida Pharmaceutical Recent Developments
  61. 7.11 Lannett Company
  62. 7.11.1 Lannett Company Company Information
  63. 7.11.2 Lannett Company Business Overview
  64. 7.11.3 Lannett Company Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Lannett Company Uric Acid-lowering Drugs Product Portfolio
  66. 7.11.5 Lannett Company Recent Developments
  67. 7.12 Horizo​​n Therapeutics
  68. 7.12.1 Horizo​​n Therapeutics Company Information
  69. 7.12.2 Horizo​​n Therapeutics Business Overview
  70. 7.12.3 Horizo​​n Therapeutics Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Horizo​​n Therapeutics Uric Acid-lowering Drugs Product Portfolio
  72. 7.12.5 Horizo​​n Therapeutics Recent Developments
  73. 7.13 Fuji Yakuhin
  74. 7.13.1 Fuji Yakuhin Company Information
  75. 7.13.2 Fuji Yakuhin Business Overview
  76. 7.13.3 Fuji Yakuhin Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Fuji Yakuhin Uric Acid-lowering Drugs Product Portfolio
  78. 7.13.5 Fuji Yakuhin Recent Developments
8 North America
  1. 8.1 North America Uric Acid-lowering Drugs Market Size by Type
  2. 8.1.1 North America Uric Acid-lowering Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Uric Acid-lowering Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Uric Acid-lowering Drugs Price by Type (2021-2032)
  5. 8.2 North America Uric Acid-lowering Drugs Market Size by Application
  6. 8.2.1 North America Uric Acid-lowering Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Uric Acid-lowering Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Uric Acid-lowering Drugs Price by Application (2021-2032)
  9. 8.3 North America Uric Acid-lowering Drugs Market Size by Country
  10. 8.3.1 North America Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Uric Acid-lowering Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Uric Acid-lowering Drugs Market Size by Type
  2. 9.1.1 Europe Uric Acid-lowering Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Uric Acid-lowering Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Uric Acid-lowering Drugs Price by Type (2021-2032)
  5. 9.2 Europe Uric Acid-lowering Drugs Market Size by Application
  6. 9.2.1 Europe Uric Acid-lowering Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Uric Acid-lowering Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Uric Acid-lowering Drugs Price by Application (2021-2032)
  9. 9.3 Europe Uric Acid-lowering Drugs Market Size by Country
  10. 9.3.1 Europe Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Uric Acid-lowering Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Uric Acid-lowering Drugs Market Size by Type
  2. 10.1.1 China Uric Acid-lowering Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Uric Acid-lowering Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Uric Acid-lowering Drugs Price by Type (2021-2032)
  5. 10.2 China Uric Acid-lowering Drugs Market Size by Application
  6. 10.2.1 China Uric Acid-lowering Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Uric Acid-lowering Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Uric Acid-lowering Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Uric Acid-lowering Drugs Market Size by Type
  2. 11.1.1 Asia Uric Acid-lowering Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Uric Acid-lowering Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Uric Acid-lowering Drugs Price by Type (2021-2032)
  5. 11.2 Asia Uric Acid-lowering Drugs Market Size by Application
  6. 11.2.1 Asia Uric Acid-lowering Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Uric Acid-lowering Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Uric Acid-lowering Drugs Price by Application (2021-2032)
  9. 11.3 Asia Uric Acid-lowering Drugs Market Size by Country
  10. 11.3.1 Asia Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Uric Acid-lowering Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Uric Acid-lowering Drugs Market Size by Type
  2. 12.1.1 SAMEA Uric Acid-lowering Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Uric Acid-lowering Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Uric Acid-lowering Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Uric Acid-lowering Drugs Market Size by Application
  6. 12.2.1 SAMEA Uric Acid-lowering Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Uric Acid-lowering Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Uric Acid-lowering Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Uric Acid-lowering Drugs Market Size by Country
  10. 12.3.1 SAMEA Uric Acid-lowering Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Uric Acid-lowering Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Uric Acid-lowering Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Uric Acid-lowering Drugs Value Chain Analysis
  2. 13.1.1 Uric Acid-lowering Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Uric Acid-lowering Drugs Production Mode & Process
  6. 13.2 Uric Acid-lowering Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Uric Acid-lowering Drugs Distributors
  9. 13.2.3 Uric Acid-lowering Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst